The effect of cisatracurium and rocuronium on cisatracurium precurarization and the priming principle

Journal of Clinical Anesthesia

Volumn 16, Issue 2, 2004, Pages 83-87

  Mak, Peter H K ^a,b   Irwin, Michael G ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anesthesia, general; Mechanisms: priming; Neuromuscular blocking agents: cisatracurium, rocuronium

Indexed keywords

CISATRACURIUM; FENTANYL DERIVATIVE; PROPOFOL; ROCURONIUM;

ADULT; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ANESTHESIA MECHANISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MUSCLE RELAXATION; MUSCLE TWITCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; UNIVERSITY HOSPITAL;

ADULT; ANDROSTANOLS; ANESTHESIA, GENERAL; ATRACURIUM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTUBATION, INTRATRACHEAL; MALE; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SEX CHARACTERISTICS; TIME FACTORS;

EID: 2142822813     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2003.05.004     Document Type: Article

References (26)

1. Foldes F. Rapid tracheal intubation with non-depolarizing neuromuscular blocking drugs the priming principle [Letter]. Br J Anaesth. 56:1984;663.
2. Naguib M., Samarkandi A.H., Ammar A., Elfaqih S.R., Al-Zahrani S., Turkistani A. Comparative clinical pharmacology of rocuronium, cisatracurium, and their combination. Anesthesiology. 89:1998;1116-1124.
3. Sheiner L.B., Stanski D.R., Vozeh S., Miller R.D., Ham J. Simulated modelling of pharmacokinetics and pharmacodynamics application to d-tubocurarine. Clin Pharmacol Ther. 25:1979;358-371.
4. Hull C.J. Pharmacodynamics of non-depolarizing neuromuscular blocking agents. Br J Anaesth. 54:1982;169-182.
5. Donati F., Meistelman C. A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs. J Pharmacokinet Biopharm. 19:1991;537-552.
6. Feldman S.A. Neuromuscular Block. 1996;110-114 Butterworth-Heinemann, Oxford, UK.
7. Schwarz S., Ilias W., Lackner F., Mayrhofer O., Foldes F.F. Rapid tracheal intubation with vecuronium the priming principle. Anesthesiology. 62:1985;388-391.
8. Matteo R.S., Ornstein E., Schwartz A.E., Ostapkovich N., Stone J.G. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg. 77:1993;1193-1197.
9. Khuenl-Brady K.S., Sparr H. Clinical pharmacokinetics of rocuronium bromide. Clin Pharmacokinet. 31:1996;174-183.
10. Kopman A.F., Khan N.A., Neuman G.G. Precurarization and priming a theoretical analysis of safety and timing. Anesth Analg. 93:2001;1253-1256.
11. Donati F. The priming saga where do we stand now? Can J Anaesth. 35:1998;1-4.
12. Magorian T., Flannery K.B., Miller R.D. Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology. 79:1993;913-918.
13. Debaene B., Lieutaud T., Billard V., Meistelman C. ORG 9487 neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans. Anesthesiology. 86:1997;1300-1305.
14. D'Honneur G., Gall O., Gerard A., Rimaniol J.M., Lambert Y., Duvaldestin P. Priming doses of atracurium and vecuronium depress swallowing in humans. Anesthesiology. 77:1992;1070-1073.
15. Aziz L., Jahangir S.M., Choudhury S.N., Rahman K., Ohta Y., Hirakawa M. The effect of priming with vecuronium and rocuronium on young and elderly patients. Anesth Analg. 85:1997;663-666.
16. Kopman A.F., Yee P.S., Neuman G.G. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 86:1997;765-771.
17. Bartkowski R.R., Epstein R.H. Relationship between train-of-four ratio and first-twitch depression during neuromuscular blockade a pharmacokinetc/ dynamic explanation. J Pharmacokinet Biopharm. 18:1990;335-346.
18. McCoy E.P., Connolly F.M., Mirakhur R.K., Loan P.B., Paxton L.D. Nondepolarizing neuromuscular blocking drugs and train-of-four fade. Can J Anaesth. 42:1995;213-216.
19. Semple P., Hope D.A., Clyburn P., Rodbert A. Relative potency of vecuronium in male and female patients in Britain and Australia. Br J Anaesth. 72:1994;190-194.
20. Xue F.S., Tong S.Y., Liao X., Liu J.H., An G., Luo L.K. Dose-response and time course of effect of rocuronium in male and female anesthetized patients. Anesth Analg. 85:1997;667-671.
21. Waud D.R. The rate of action of competitive neuromuscular blocking agents. J Pharmacol Exp Ther. 158:1967;99-114.
22. Armstrong D.L., Lester H.A. The kinetics of tubocurarine action and restricted diffusion within the synaptic cleft. J Physiol. 294:1979;365-386.
23. Proost J.H., Wierda J.M., Meijer D.K. An extended pharmacokinetic/ pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs. J Pharmacokinet Biopharm. 24:1996;45-77.
24. Wierda J.M., Proost J.H. Structure-pharmacodynamic-pharmacokinetic relationships of steroidal neuromuscular blocking agents. Eur J Anaesthesiol Suppl. 11:1995;45-54.
25. Jones R.M. The priming principle how does it work and should we be using it? Br J Anaesth. 63:1989;1-3.
26. Sparr H.J. Choice of the muscle relaxant for rapid-sequence induction. Eur J Anaesthesiol Suppl. 23:2001;71-76.